Evidence map›Paper›PMID 40675648›Full record

ArticleBMJ open2025

Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study.

Ruwani Peiris, Rachel Webb, Julie Bennett, Jennifer Yan, Joshua Reginald Francis, Bo Remenyi, Florina Chan Mow, Rachel Burgess, Nigel J Wilson, Alicia Stanley and 13 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Acute rheumatic fever and rheumatic heart disease.Nature reviews. Disease primers · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ruwani PeirisGlobal and Tropical Health, Menzies School of Health Research, Tiwi, Northern Territory, Australia.ORCID http://orcid.org/0000-0003-4008-0319
Rachel WebbKidz First Children's Hospital and Community Health Centre for Youth Health, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-9855-3919
Julie BennettDepartment of Public Health, University of Otago, Wellington, New Zealand.
Jennifer YanGlobal and Tropical Health, Menzies School of Health Research, Tiwi, Northern Territory, Australia.
Joshua Reginald FrancisGlobal and Tropical Health, Menzies School of Health Research, Tiwi, Northern Territory, Australia.ORCID http://orcid.org/0000-0001-9302-4543
Bo RemenyiRoyal Darwin Hospital, Casuarina, Northern Territory, Australia.
Florina Chan MowKidz First Children's Hospital and Community Health Centre for Youth Health, Auckland, New Zealand.
Rachel BurgessThe Kids Research Institute Australia, Nedlands, Western Australia, Australia.
Nigel J WilsonStarship Children's Health, Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-0551-4655
Alicia StanleyStarship Children's Health, Auckland, Auckland, New Zealand.
Laura FrancisRoyal Darwin Hospital, Casuarina, Northern Territory, Australia.
Rhonda HollowayStarship Children's Health, Auckland, Auckland, New Zealand.
Roxanne WestburyStarship Children's Health, Auckland, Auckland, New Zealand.
Shirley LawrenceKidz First Children's Hospital and Community Health Centre for Youth Health, Auckland, New Zealand.
Yolanda Hernandez-GomezRoyal Darwin Hospital, Casuarina, Northern Territory, Australia.
David BroadhurstSchool of Science, Edith Cowan University, Perth, Western Australia, Australia.ORCID http://orcid.org/0000-0003-0775-9581
Nicole J MorelandDepartment of Molecular Medicine and Pathology, The University of Auckland School of Medical Sciences, Auckland, New Zealand.
Reuben McGregorDepartment of Molecular Medicine and Pathology, The University of Auckland School of Medical Sciences, Auckland, New Zealand.
Caroline MotteramThe Kids Research Institute Australia, Nedlands, Western Australia, Australia.
Glenn PearsonThe Kids Research Institute Australia, Nedlands, Western Australia, Australia.
Mark MayoGlobal and Tropical Health, Menzies School of Health Research, Tiwi, Northern Territory, Australia.
Anna P Ralph *Global and Tropical Health, Menzies School of Health Research, Tiwi, Northern Territory, Australia anna.ralph@menzies.edu.au.ORCID http://orcid.org/0000-0002-2253-5749
Jonathan R Carapetis *The Kids Research Institute Australia, Nedlands, Western Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe diagnostic and management characteristics of acute rheumatic fever (ARF) among participants in the 'Searching for a Technology-Driven Acute Rheumatic Fever Test' study, in order to answer clinical questions and determine epidemiological and practice differences in different settings.

designMultisite, prospective cohort study.

settingOne hospital in northern Australia and two hospitals in New Zealand, 2018-2021.

participants143 episodes of definite, probable or possible ARF among 141 participants (median age 10 years, range 5-23; 98% Indigenous). PRIMARY AND SECONDARY OUTCOME MEASURES: Participant characteristics, clinical, biochemical and echocardiographic data were explored using descriptive data. Associations with length of stay were determined using multivariable regression analysis.

resultsARF presentations were heterogeneous with the most common ARF 'phenotype' in 19% of cases being carditis with joint manifestations (polyarthritis, monarthritis or polyarthralgia), fever and PR prolongation. The total proportion of children with carditis was 61%. Australian compared with New Zealand participants more commonly had ARF recurrence (22% vs 0%), underlying RHD (48% vs 0%), possible/probable ARF (23% vs 9%) and were underweight (64% vs 16%). Erythrocyte sedimentation rate (ESR) provided an incremental diagnostic yield of 21% compared with C reactive protein. No instances of RHD were diagnosed among participants in New Zealand. Positive throat Group A Streptococcus culture was more common in New Zealand than in Australian participants (69% vs 3%). Children often required prolonged hospitalisation, with median hospital length-of-stay being 7 days (range 2-66). Significant predictors for length of stay in a multivariable regression model were valve disease (adjusted OR (aOR) 1.56, 95% CI 1.23 to 1.98, p<0.001), requirement for corticosteroids (aOR 1.99, 95% CI 1.22 to 3.26, p=0.007) and higher ESR (aOR 1.4, 95% CI 1.17 to 1.67, p<0.001).

conclusionsThis study provides new knowledge on ARF characteristics and management and highlights international variation in diagnostic and management practice. Differing approaches need to be aligned. Meanwhile, locally specific information can help guide patient expectations after ARF diagnosis.

Indexed as

Rheumatic FeverAdolescentAustraliaBlood SedimentationChildChild, PreschoolFemaleHumansLength of StayMaleNew ZealandProspective StudiesYoung AdultCardiovascular DiseaseEpidemiologyPAEDIATRICSPublic health

Identifiers

PMID40675648
PMCPMC12273072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.